New York Life Investment Management’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-25,914
Closed -$367K 1289
2024
Q1
$367K Buy
+25,914
New +$367K ﹤0.01% 1048